Sleep studies in ESRD patients have identified increased prevalence of Sleep Apnea. Based on
current knowledge, treatment aimed at reducing oxidative stress might improve Sleep Apnea in
HD patients. The aim of our study is to investigate the effect of N-acetylsysteine on Sleep
Apnea in HD patients.